Results 51 to 60 of about 1,463 (147)
Micropulse cyclophotocoagulation (MP-CPC) refers to interventions that reduce intraocular pressure by laser exposure on the ciliary body, while the term “coagulation” in its name does not reflect the essence of the procedure, but is inherited from the ...
O. V. Ermakova, E. A. Ragozina
doaj +1 more source
Tomas M Grippo,1 Ronald MPC de Crom,2 Michael Giovingo,3 Marc Töteberg-Harms,4 Brian A Francis,5 Brian Jerkins,6 Jacob W Brubaker,7 Nathan Radcliffe,8 Jella An,9 Robert Noecker10 1Department of Ophthalmology, Hospital Aleman, Buenos Aires, Argentina ...
Grippo TM +9 more
doaj
Purpose: To evaluate the effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema (DME).
Mohammadreza Akhlaghi +4 more
doaj +1 more source
Objectiv To evaluate the efficacy of subthreshold micropulse yellow (577 nm) laser photocoagulation in diffuse macular edema (DME) in rural and urban patients of south-eastern Poland.
Małgorzata Latalska +3 more
doaj +1 more source
Background To evaluate if a combination therapy with micropulse diode laser (MPL) shows non-inferiority on visual acuity (BCVA) within 12 months in comparison to standard therapy, i.e. intravitreal injection of ranibizumab alone.
Olga Furashova +3 more
doaj +1 more source
Our first experience with subtreshold diode laser in the treatment of macular edema
Authors describe their first experience with the treatment of macular edema of different etiology with subtreshold diode micropulse laser (577 nm), which does not cause any damage to the retinal pigment epithelium.
Davorin Sevšek +2 more
doaj
INTRODUCTION: Central serous chorioretinopathy (CSC) is a disease characterized by idiopathic serous elevation of the sensory layer of the retina in the proximity of the macula.
Maciej Michalik +3 more
doaj +1 more source
Micropulse P3™ (MP3) Laser for Glaucoma: An Innovative Therapy
How to cite this article: Aquino MC, Lim D, Chew PTK. Micropulse P3™(MP3) Laser for Glaucoma: An Innovative Therapy. J Curr Glaucoma Pract 2018;12(2):51-52.
Aquino, Maria Cecilia +2 more
openaire +2 more sources
Background In the UK, macular laser is the treatment of choice for people with diabetic macular oedema with central retinal subfield thickness (CST)
Noemi Lois +27 more
doaj +1 more source
Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
Ahmed Hosni Abd ElhamidDepartment of Ophthalmology, Ain Shams University, Cairo, EgyptPurpose: To report the efficacy and safety of micropulse 577 nm yellow laser in the treatment of nonresolving central serous chorioretinopathy (CSC) cases.Patients
Abd Elhamid AH
doaj

